Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 02, 2025 08:00 ET | Source: Cizzle Bio

Cizzle Bio Announces Live Investor Webinar on Transforming Lung Cancer Detection

San Antonio, TX, July 02, 2025 (GLOBE NEWSWIRE) -- Cizzle Bio today announced a live investor webinar scheduled for July 15, 2025, at 1:30 PM PST that will showcase the company’s patented blood test...
June 05, 2025 09:26 ET | Source: Research and Markets

Global Oncology Collaboration and Licensing Deals Report 2020-2025: 3,350 Biopharma Agreements Analyzed with Financial Terms, Partnering Trends, and Contract Insights

Dublin, June 05, 2025 (GLOBE NEWSWIRE) -- The "Oncology Collaboration and Licensing Deals 2020-2025" report has been added to ResearchAndMarkets.com's offering.Oncology Collaboration and Licensing...
May 20, 2025 12:17 ET | Source: Research and Markets

U.S. Interventional Oncology Market Worth $1.59 Billion by 2030: Analysis of Revenue Shares by Technique, Procedure, Application and End Use

Dublin, May 20, 2025 (GLOBE NEWSWIRE) -- The "U.S. Interventional Oncology Market Size, Share & Trends Analysis Report by Technique (Ablation Therapies, Embolization Therapies), Procedure (Tumor...
May 08, 2025 04:22 ET | Source: Research and Markets

Anti-Cancer MAbS Market Research Report 2025: Rising Cancer Incidence Spurs Demand for Targeted Anti-Cancer MAbS Treatments - Historic Trends and Forecasts, 2019-2024, 2024-2029F, 2034F

Dublin, May 08, 2025 (GLOBE NEWSWIRE) -- The "Anti-Cancer MAbS Market Report 2025" has been added to ResearchAndMarkets.com's offering. The anti-cancer monoclonal antibodies (mAbs) market is...
May 05, 2025 09:33 ET | Source: Research and Markets

Oncology Liquid Biopsy Market Outlook 2025-2035: Early Detection and Personalized Medicine Propel Widespread Adoption of Liquid Biopsy Technologies

Dublin, May 05, 2025 (GLOBE NEWSWIRE) -- The "Oncology Liquid Biopsy Market - A Global and Regional Analysis: Focus on Offering, Indication, Clinical Application, End User and Country-Level Analysis...
April 28, 2025 10:21 ET | Source: Research and Markets

Targeted Therapies for Non-Small Cell Lung Cancer (NSCLC): Addressing Ten Actionable Genomic Alterations in a Competitive Market

Dublin, April 28, 2025 (GLOBE NEWSWIRE) -- The "Current Trends in Targeted Therapies in Non-Small Cell Lung Cancer (NSCLC)" report has been added to ResearchAndMarkets.com's offering. This report...
March 24, 2025 08:00 ET | Source: Noah Medical

Noah Medical’s Galaxy System Surpasses 5,000 Procedures, Marking a New Era in Robotic-Assisted Bronchoscopy

Noah Medical’s Galaxy System™ Surpasses 5,000 Procedures, Marking a New Era in Robotic-Assisted Bronchoscopy
March 18, 2025 11:47 ET | Source: Lung Cancer Foundation of America

Lung Cancer Foundation of America (LCFA) Announces the Appointment of Dr. Drew Moghanaki To Its Scientific Advisory Board

Los Angeles, CA, March 18, 2025 (GLOBE NEWSWIRE) -- Lung Cancer Foundation of America (LCFA) is pleased to welcome Radiation Oncologist Dr. Drew Moghanaki to its Scientific Advisory Board (SAB). Dr....
March 06, 2025 07:30 ET | Source: Plus Therapeutics Inc.

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of Leptomeningeal Metastases in Patients with Lung Cancer

Plus Therapeutics Granted U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the Treatment of Leptomeningeal Metastases in Patients with L
March 04, 2025 07:09 ET | Source: Transparency Market Research

PD-1 Inhibitor Drugs Market Surges with Expanding Immunotherapy Applications, Set to Cross $201.5 Billion by 2035 | Latest Report by TMR

Wilmington, Delaware, United States, Transparency Market Research Inc. – , March 04, 2025 (GLOBE NEWSWIRE) -- The Global PD-1 Inhibitor Drugs Market, valued at US$ 41.4 billion in 2024, is set for...

Next Page keyboard_arrow_right